Meningococcal vaccines are used in the treatment of meningitis, septicemia, meningococcemia and pneumonia. Meningitis is characterized by inflammation of the membranes covering the brain and spinal cord. This type of inflammation is caused by infection of bacteria, viruses and by drugs.

1. Meningococcal Vaccines Market: Global Industry Analysis and Forecast to 2020
Persistence Market Research
Meningococcal Vaccines Market: Global
Industry Analysis and Forecast to 2020
Persistence Market Research 1

2. Meningococcal Vaccines Market: Global Industry Analysis and Forecast to 2020
Persistence Market Research Released New Market Report on “Meningococcal Vaccines
Market: Global Industry Analysis and Forecast to 2020”.
Meningococcal vaccines are used in the treatment of meningitis, septicemia, meningococcemia and
pneumonia. Meningitis is characterized by inflammation of the membranes covering the brain and spinal
cord. This type of inflammation is caused by infection of bacteria, viruses and by drugs.
Based on various cause of the disease, meningitis is classified into two main types: non-infectious
meningitis and infectious meningitis. Non-infectious meningitis is a type of aseptic meningitis. Aseptic
meningitis is caused by something other than the bacteria that typically cause acute meningitis. Non-
infectious meningitis does not spread from person to person. Infectious meningitis is further sub-divided
into bacterial meningitis, fungal meningitis, viral meningitis and parasitic meningitis. Bacterial meningitis is
extremely severe form of the disease which is caused by bacteria such as Haemophilus influenzae,
Neisseria meningitidis and Streptococcus pneumonia. These bacteria can spread from person to person
through coughing and sneezing. Viral meningitis is mainly occurred by diarrhea causing virus. Fungal
meningitis is rare in healthy people. However, person who has an impaired immune system is more
prevalent with this form of the disease.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/meningococcal-
vaccines-market.asp
Septicemia arises from infections throughout the body. It includes infections in the lungs, urinary tract and
abdomen. Meningococcemia is also caused by bacterium Neisseria meningitidis.
The global meningococcal vaccines market is segmented into conjugate vaccines, polysaccharide
vaccines and combination vaccines. Conjugate vaccines reduce incidences of bacterial meningitis. This is
due to prolonged immunization influence of the vaccine which is developed for various serogroups of
bacteria. Major brands of conjugate vaccines include MenAfriVac, Nimenrix, Menactra, Meningitec,
NeisVac-C and Menveo.
Polysaccharide provides immunity for a short period of time. Major brands of polysaccharide vaccines
include NmVac4, Menomune, Bi Meningo, Mencevax and Quadri Meningo.
Combination vaccines are prepared with the combination of other microorganism. Major brands of
combination vaccines include Menitorix and MenHibrix.
In terms of geographic, North America dominates the global meningococcal vaccines market. This is due
to increased healthcare awareness in the region. The U.S. represents the largest market for
Persistence Market Research 2

3. Meningococcal Vaccines Market: Global Industry Analysis and Forecast to 2020
meningococcal vaccines followed by Canada in North America. In Europe, France, Germany and the U.K.
holds major share of meningococcal vaccines market. However, Asia is expected to show high growth
rates in the next five years in global meningococcal vaccines market. This is due to increasing awareness
among people about meningitis in the region. Several government associations have launched various
immunization programs and awareness campaigns to provide education about meningococcal disease.
Japan, China and India are expected to be the fastest growing meningococcal vaccines markets in Asia.
In recent time, increased government support is key driver for the global meningococcal vaccines market.
Various government associations have launched mandate immunization programs for school children.
This increases the demand of meningococcal vaccines to provide immunity against meningococcal
disease.
However, stringent regulations hamper the growth of global meningococcal vaccines market. Increasing
mergers and acquisitions between manufacturing companies and government bodies and rapid product
launches are some of the major trends of global meningococcal vaccines market.
Some of the major companies operating in the global meningococcal vaccines market are
GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG, Sanofi SA, Pfizer,
Inc. and Baxter International, Inc..
Request Full TOC: http://www.persistencemarketresearch.com/toc/3640
Key points covered in the report:-
1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
 North America
 Europe
 Asia
 RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research 3

4. Meningococcal Vaccines Market: Global Industry Analysis and Forecast to 2020
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions
PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/
Persistence Market Research 4